CHEMO-FREE TRIPLET COMBINATION OF TGR-1202, UBLITUXIMAB,...

Hematological Oncology 2017 / 06 Vol. 35

CHEMO-FREE TRIPLET COMBINATION OF TGR-1202, UBLITUXIMAB, AND IBRUTINIB IS WELL TOLERATED AND HIGHLY ACTIVE IN PATIENTS WITH ADVANCED CLL AND NHL.

Nastoupil, L., Lunning, M.A., Vose, J.M., Schreeder, M.T., Siddiqi, T., Flowers, C.R., Cohen, J.B., Burger, J.A., Wierda, W.G., O'Brien, S., Sportelli, P., Miskin, H.P., Purdom, M.A., Weiss, M.S., Fow
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2437_101
Date:
June, 2017
File:
PDF, 90 KB
english, 2017
Conversion to is in progress
Conversion to is failed